Control of occult hepatitis B virus infection
| dc.contributor.author | Lalana Garcés, Marta | |
| dc.contributor.author | Ortiz Pastor, Oihana | |
| dc.contributor.author | Solé Enrech, Gemma | |
| dc.contributor.author | Guerra Ruiz, Armanado R. | |
| dc.contributor.author | Casals Mercadal, Gregori | |
| dc.contributor.author | Almería Lafuente, Alejandro | |
| dc.contributor.author | Ballesteros Vizoso, María Antonieta | |
| dc.contributor.author | Gabriel Medina, Pablo | |
| dc.contributor.author | Salgüero Fernández, Sergio | |
| dc.contributor.author | Zamora Trillo, Angielys | |
| dc.contributor.author | Aured de la Serna, Isabel | |
| dc.contributor.author | Hurtado, Juan Carlos | |
| dc.contributor.author | Pérez del Pulgar Gallart, Sofía | |
| dc.contributor.author | Forns, Xavier | |
| dc.contributor.author | Morales Ruiz, Manuel | |
| dc.date.accessioned | 2023-07-04T13:51:40Z | |
| dc.date.available | 2023-07-04T13:51:40Z | |
| dc.date.issued | 2022-08-15 | |
| dc.date.updated | 2023-07-03T09:50:34Z | |
| dc.description.abstract | Background: The diagnosis of hepatitis B virus (HBV) infection requires HBV DNA testing and serologic testing for detection of the surface antigen (HBsAg) and the hepatitis B core antibody (anti-HBc). There is a population of patients with occult HBV infection (OBI), which is not detected by HBsAg or HBV DNA quantification in blood, despite the presence of active replication in the liver.Scope: This document provides a definition of OBI and describes the diagnostic techniques currently used. It also addresses the detection of patients with risk factors and the need for screening for OBI in these patients.Summary:Correct diagnosis of OBI prevents HBV reactivation and transmission. Diagnosis of OBI is based on the detection of HBV DNA in patients with undetectable HBsAg in blood.Perspectives: A high number of patients with OBI may remain undiagnosed; therefore, screening for OBI in patients with factor risks is essential. For a correct diagnosis of OBI, it is necessary that new markers such as ultrasensitive HBsAg are incorporated, and a more comprehensive marker study is performed by including markers such as cccDNA. | |
| dc.format.extent | 10 p. | |
| dc.format.mimetype | application/pdf | |
| dc.identifier.idimarina | 9346686 | |
| dc.identifier.issn | 2628-491X | |
| dc.identifier.pmid | 37363431 | |
| dc.identifier.uri | https://hdl.handle.net/2445/200265 | |
| dc.language.iso | eng | |
| dc.publisher | De Gruyter | |
| dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.1515/almed-2022-0065 | |
| dc.relation.ispartof | Advances In Laboratory Medicine, 2022, vol. 3, num. 4, p. 321-330 | |
| dc.relation.uri | https://doi.org/10.1515/almed-2022-0065 | |
| dc.rights | cc by (c) Lalana Garcés, Marta et al, 2022 | |
| dc.rights.accessRights | info:eu-repo/semantics/openAccess | |
| dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es/ | * |
| dc.source | Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer) | |
| dc.subject.classification | Hepatitis B | |
| dc.subject.classification | Serodiagnòstic | |
| dc.subject.other | Hepatitis B | |
| dc.subject.other | Serodiagnosis | |
| dc.title | Control of occult hepatitis B virus infection | |
| dc.type | info:eu-repo/semantics/other | |
| dc.type | info:eu-repo/semantics/publishedVersion |
Fitxers
Paquet original
1 - 1 de 1
Carregant...
- Nom:
- Control of occult hepatitis B virus infection_AdvLabMed.pdf
- Mida:
- 688.49 KB
- Format:
- Adobe Portable Document Format